Biotechnology firm Biocon Ltd announces its board's approval to acquire optionally convertible debentures of its subsidiary ...

Biocon Ltd acquires Biocon Biologics debentures from Goldman Sachs for USD 198.5 million. The acquisition involves 1,125 ...

Biocon Share Price Today (26th Jun, 2025): Check Biocon Stock Price live NSE/BSE on financialexpress.com. Get Biocon today's stock price, 52-week high, 52-week low, Biocon quarterly results, share ...

Biocon’s growth story has long been muted — until now. With Viatris in its fold and a strong biosimilars pipeline, the ...

S&P says Biocon will bring down adjusted debt to Rs 20,000 crore by FY26 through equity issuance, with strong cash flows ...

Shares of Biocon were up 1.7% at ₹348.35 on Thursday, after falling 4.3% in the previous two sessions. The pharma company is ...

Siddharth Mittal, CEO & MD of Biocon says the company will evaluate Biologics IPO after committee review; current focus is on ...

The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control ...

Biocon intends to utilise the proceeds to repay some of its outstanding debt and to purchase the outstanding optionally ...

Biocon said the proceeds from the QIP will be utilised for purchase of outstanding optionally convertible debentures issued by its subsidiary.

The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

Bengaluru-based Biocon Ltd. closes the window to list its arm, Biocon Biologics Ltd., as it raises Rs 4,500 crore to provide ...